Literature DB >> 7001940

Rhabdomyosarcoma.

L S Bizer.   

Abstract

The care of patients with rhabdomyosarcoma has undergone significant change in the past decade. Careful staging and multidisciplinary treatment have improved the prognosis for patients with this neoplasm. A review of the medical literature of the past decade documents these changes in staging, therapy and prognosis.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7001940     DOI： 10.1016/0002-9610(80)90059-8

Source DB:  PubMed          Journal:  Am J Surg        ISSN： 0002-9610            Impact factor:   2.565


  3 in total

1.  Oncogenic NRAS, required for pathogenesis of embryonic rhabdomyosarcoma, relies upon the HMGA2-IGF2BP2 pathway.

Authors:  Zhizhong Li; Yunyu Zhang; Krishnan Ramanujan; Yan Ma; David G Kirsch; David J Glass
Journal:  Cancer Res       Date:  2013-03-27       Impact factor: 12.701

2.  Childhood cancer survival trends in Queensland 1956-80.

Authors:  W R McWhirter; V Siskind
Journal:  Br J Cancer       Date:  1984-04       Impact factor: 7.640

3.  Oncogenic role of HMGA2 in fusion-negative rhabdomyosarcoma cells.

Authors:  Kazutaka Ouchi; Mitsuru Miyachi; Shigeki Yagyu; Ken Kikuchi; Yasumichi Kuwahara; Kunihiko Tsuchiya; Tomoko Iehara; Hajime Hosoi
Journal:  Cancer Cell Int       Date:  2020-05-24       Impact factor: 5.722
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.